Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.56 |
| ▸ | USP2 | O75604 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | CASP1 | P29466 | 4/20 | 0.56 |
| ▸ | CASP7 | P55210 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | HKDC1 | Q2TB90 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | GLA | P06280 | 3/20 | 0.56 |
| ▸ | TNNI3 | P19429 | 2/20 | 0.56 |
| ▸ | TNNT2 | P45379 | 2/20 | 0.56 |
| ▸ | TNNC1 | P63316 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17653968 | 0.90 | PPARG (0.59) | SLC28A3USP2KDM4EHPGDCASP1 | |
| Pungenin SCHEMBL29613656 | 0.89 | SLC28A3 (0.65) | SLC28A3KDM4EHPGDCASP1CASP7 | |
| SCHEMBL5181436 | 0.87 | USP2 (0.57) | SLC28A3USP2KDM4EHPGDCASP1 | |
| SCHEMBL722959 | 0.87 | USP2 (0.57) | SLC28A3USP2KDM4EHPGDCASP1 | |
| SCHEMBL4375057 | 0.87 | USP2 (0.57) | SLC28A3USP2KDM4EHPGDCASP1 | |
| SCHEMBL29711107 | 0.86 | SLC28A3 (0.56) | SLC28A3KDM4EHPGDCASP1CASP7 | |
| SCHEMBL13576873 | 0.86 | USP2 (0.60) | SLC28A3USP2KDM4EHPGDCASP1 | |
| SCHEMBL5181812 | 0.86 | USP2 (0.60) | SLC28A3USP2KDM4EHPGDCASP1 | |
| SCHEMBL13577086 | 0.86 | USP2 (0.60) | SLC28A3USP2KDM4EHPGDCASP1 | |
| SCHEMBL3232003 | 0.86 | USP2 (0.60) | SLC28A3USP2KDM4EHPGDCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4062774-B1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING INCREASED PHENYLALANINE AND REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | ALTRIA CLIENT SERVICES LLC (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20230348925-A1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | ALTRIA CLIENT SERVICES LLC (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230109671-A9 | Composition and Methods for Producing Tobacco Plants and Products Having Reduced Tobacco-Specific Nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC | 2023-04-06 | — | — | US | disclosed |
| EP-4062774-A1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING INCREASED PHENYLALANINE AND REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | Altria Client Services LLC (US) | 2022-09-28 | — | — | EP | disclosed |
| EP-3773017-B1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING INCREASED PHENYLALANINE AND REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | ALTRIA CLIENT SERVICES LLC (US) | 2022-06-08 | — | — | EP | disclosed |
| US-10647989-B2 | Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC (US) | 2020-05-12 | — | — | US | disclosed |
| US-20180119163-A1 | Composition and Methods for Producing Tobacco Plants and Products Having Reduced Tobacco-Specific Nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC | 2018-05-03 | — | — | US | disclosed |
| US-9895341-B2 | Inflammation and immunity treatments | OCEAN SPRAY CRANBERRIES, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-9828407-B2 | Water soluble and activable phenolic derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives | LIBRAGEN (FR) | 2017-11-28 | — | — | US | disclosed |
| US-20140134206-A1 | INFLAMMATION AND IMMUNITY TREATMENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140088030-A1 | WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES | LIBRAGEN (FR) | 2014-03-27 | — | — | US | disclosed |
| WO-2012135702-A1 | INFLAMMATION AND IMMUNITY TREATMENTS | OCEAN SPRAY CRANBERRIES, INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| EP-2027279-B1 | Phenolic compounds with cosmetic and therapeutic applications | LIBRAGEN (FR) | 2012-04-18 | — | — | EP | disclosed |
| US-20090233876-A1 | Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives | LIBRAGEN (FR) | 2009-09-17 | — | — | US | disclosed |
| EP-1867729-A1 | Water soluble phenolics derivatives with dermocosmetic and therapeutic applications | Libragen (FR) | 2007-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233876-A1 | Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives | UGGT1, TYR, LCT | SLC28A3 2244/4885USP2 2372/4885KDM4E 1025/4885 |
| US-20140088030-A1 | WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES | UGGT1, TYR, G6PD | SLC28A3 2443/4885USP2 2241/4885KDM4E 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.